InMed Pharmaceuticals (INM) Other Non Operating Income (2019 - 2026)
InMed Pharmaceuticals (INM) posted Other Non Operating Income of -$23168.0 for Q1 2026, down 227.75% on a QoQ basis from $18136.0 in Q4 2025, and down 4.53% year-over-year from -$24266.1 in Q1 2025.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Other Non Operating Income (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Other Non Operating Income for 8 years, with the latest figure at -$23168.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 4.53% year-over-year to -$23168.0 in Q1 2026; TTM through Mar 2026 was -$39889.0, a 47.38% increase from a year earlier, with the FY2025 full-year figure at -$28471.0, up 54.02% from the prior year.
- Other Non Operating Income was -$23168.0 for Q1 2026 at InMed Pharmaceuticals, down from $18136.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $59896.0 in Q4 2023, with the low at -$96791.0 in Q3 2022.
- Average Other Non Operating Income over 5 years is -$13943.5, with a median of -$22165.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 573.0% in 2022, then plunged 1662.02% in 2024.
- Over 5 years, Other Non Operating Income stood at $20237.0 in 2022, then soared by 195.97% to $59896.0 in 2023, then slumped by 179.73% to -$47753.0 in 2024, then soared by 137.98% to $18136.0 in 2025, then slumped by 227.75% to -$23168.0 in 2026.
- The last three Other Non Operating Income figures came in at -$23168.0 (Q1 2026), $18136.0 (Q4 2025), and -$56994.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Corning | 145.42 Bn | 142.92 Bn | 1.63 Bn |
| 2 | Ati | 28.33 Bn | 27.54 Bn | 309.80 Mn |
| 3 | Qnity Electronics | 26.44 Bn | 25.48 Bn | 666.00 Mn |
| 4 | International Flavors & Fragrances | 21.63 Bn | 21.06 Bn | 853.00 Mn |
| 5 | DuPont de Nemours | 17.55 Bn | 15.81 Bn | 639.00 Mn |
| 6 | Avery Dennison | 13.07 Bn | 12.84 Bn | 729.40 Mn |
| 7 | Solstice Advanced Materials | 10.13 Bn | 9.38 Bn | 370.00 Mn |
| 8 | Element Solutions | 8.78 Bn | 8.59 Bn | 334.00 Mn |
| 9 | Eastman Chemical | 7.87 Bn | 7.18 Bn | 560.00 Mn |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -23,168.00 |
| Dec 31, 2025 | 18,136.00 |
| Sep 30, 2025 | -56,994.00 |
| Jun 30, 2025 | 22,137.00 |
| Mar 31, 2025 | -22,165.00 |
| Dec 31, 2024 | -47,753.00 |
| Sep 30, 2024 | 19,310.00 |
| Jun 30, 2024 | -25,204.00 |
| Mar 31, 2024 | -48,156.00 |
| Dec 31, 2023 | 59,896.00 |
| Sep 30, 2023 | -48,457.00 |
| Jun 30, 2023 | 31,112.00 |
| Mar 31, 2023 | -2,733.00 |
| Dec 31, 2022 | 20,237.00 |
| Sep 30, 2022 | -96,791.00 |
| Jun 30, 2022 | -69,442.00 |
| Mar 31, 2022 | 32,996.00 |
| Dec 31, 2021 | 3,007.00 |
| Sep 30, 2021 | -84,112.00 |
| Mar 31, 2021 | 28,467.00 |